National Pediatric Rehabilitation Resource Center: Techniques Development
国家儿科康复资源中心:技术开发
基本信息
- 批准号:10400684
- 负责人:
- 金额:$ 14.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-15 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AdherenceAdvanced DevelopmentAgeAreaAssessment toolBehaviorBehavioralBiological MarkersBiomedical ResearchBrainCategoriesCerebral PalsyChildChildhoodClinicalClinical TrialsCommon Data ElementCommunitiesData ReportingDocumentationEnvironmentEtiologyFailureFrequenciesFunctional Magnetic Resonance ImagingFutureImpairmentIncentivesIndividualInfantInterventionLaboratoriesMeasuresMentorsMethodsModificationMovementNeuronal PlasticityOhioOutcome MeasureParentsPatient Self-ReportPatternPediatric HospitalsPerformancePropertyPsychometricsRehabilitation therapyReportingResearchResearch InstituteResearch PersonnelResourcesRestScienceScientistScoring MethodSenior ScientistSeveritiesSleepSpecificityStandardizationTechniquesTechnologyTestingTimeTreatment ProtocolsUniversitiesValidationVideo GamesVirginiaWorkbaseclinical applicationclinical practiceconstraint induced movement therapydata standardsdosagefunctional near infrared spectroscopykinematicsneuroimagingnovelnovel strategiesoff-label useprimary outcomerehabilitation researchrobotic devicesecondary outcomeskillstechnique developmenttechnology developmenttoolwearable device
项目摘要
Project Summary (Techniques Development)
The National Pediatric Rehabilitation Resource Center (PedRehab Ctr) will engage in development of techniques
we consider highly promising, responsive to critical gaps in methods or technology in the field, and potentially
multi-purpose in their application. Specifically, the areas we propose to pursue have application for both research
and clinical practice. Pediatric rehabilitation research would benefit immensely from more sensitive, valid, and
reliable approaches to measuring the emergence of new skills and their use in everyday function. Many tools in
the new Common Data Elements (CDEs) for Cerebral Palsy were developed initially for typically developing
children; others apply to only limited age ranges but often are used “off label;” and some designated as
“exploratory” or “highly promising” lack confirmation (and likely further refinement) of their psychometric
properties. Another major problem in pediatric rehabilitation trials has been the failure to measure Fidelity of
Treatment (i.e., adherence to intended treatment protocols). Our PedRehab Ctr scientists have been active in
developing and validating novel assessment tools from sophisticated kinematics to parent report tools; creating
first ever Fidelity of Treatment tools for pediatric Constraint-Induced Movement Therapy and Bimanual treatment;
and exploring the incorporation of various neuroimaging approaches to document treatment-induced
neuroplasticity. Our specific aims for Techniques Development are:
1. To obtain confirmatory documentation of assessment methods for function, skill, and behaviors that go
across laboratory and real-world environments. This includes use of kinematics and video-, game-,
robotic-, and wearable-devices to supplement traditional standardized tests and systematic methods for
establishing clinically meaningful thresholds for gain and losses;
2. To standardize modifications and summary scoring methods of currently used tools to allow for greater
specificity and for use with children who vary widely in age, severity, and etiologies of neuromotor
impairments;
3. To advance the development of Fidelity of Treatment measures to provide much-needed
documentation of the actual delivery of rehabilitation interventions; and
4. To explore novel neuroimaging strategies for use as individual biomarkers and as valid, reliable
indicators of treatment-induced neuroplasticity.
项目总结(技术开发)
国家儿科康复资源中心(PedRehab Ctr)将从事技术开发
我们认为非常有希望,对该领域方法或技术的关键差距做出反应,并有可能
在它们的应用中具有多用途。具体地说,我们建议研究的领域适用于这两项研究
和临床实践。儿科康复研究将极大地受益于更加敏感、有效和
衡量新技能的出现及其在日常工作中的使用的可靠方法。中的许多工具
新的脑瘫通用数据元素(CDE)最初是为典型开发而开发的
儿童;其他儿童只适用于有限的年龄范围,但通常被用在“标签外”;还有一些被指定为
“探索性的”或“极有希望的”缺乏对其心理测量的确认(可能还会进一步完善)。
属性。儿科康复试验中的另一个主要问题是未能衡量
治疗(即,遵守预定的治疗方案)。我们的儿科康复中心的科学家们一直活跃在
开发和验证新的评估工具,从复杂的运动学到父报告工具;创建
儿童强迫诱导运动疗法和双指甲疗法治疗工具的首次保真度;
并探索结合各种神经成像方法来记录治疗引起的
神经可塑性。我们的技术开发的具体目标是:
1.获取功能、技能和行为评估方法的确认性文件
跨越实验室和现实世界环境。这包括运动学和视频的使用,游戏,
机器人和可穿戴设备,以补充传统的标准化测试和系统方法
建立具有临床意义的得失阈值;
2.将当前使用的工具的修改和汇总评分方法标准化,以实现更大的
适用于年龄、严重程度和神经运动病因差异很大的儿童
减值;
3.为推进保真发展提供急需的治疗措施
实际提供康复干预措施的文件记录;以及
4.探索新的神经成像策略,作为单独的生物标记物和有效、可靠的
治疗诱导的神经可塑性指标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JILL C. HEATHCOCK其他文献
JILL C. HEATHCOCK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JILL C. HEATHCOCK', 18)}}的其他基金
Development of upper extremity behavioral assessment methods for reach-and-grasp and physical rehabilitation
开发用于伸手抓握和身体康复的上肢行为评估方法
- 批准号:
10467762 - 财政年份:2022
- 资助金额:
$ 14.14万 - 项目类别:
Development of upper extremity behavioral assessment methods for reach-and-grasp and physical rehabilitation
开发用于伸手抓握和身体康复的上肢行为评估方法
- 批准号:
10707938 - 财政年份:2022
- 资助金额:
$ 14.14万 - 项目类别:
National Pediatric Rehabilitation Resource Center: Techniques Development
国家儿科康复资源中心:技术开发
- 批准号:
10163242 - 财政年份:2020
- 资助金额:
$ 14.14万 - 项目类别:
National Pediatric Rehabilitation Resource Center: Techniques Development
国家儿科康复资源中心:技术开发
- 批准号:
10625510 - 财政年份:2020
- 资助金额:
$ 14.14万 - 项目类别:
相似海外基金
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
- 批准号:
10935820 - 财政年份:2023
- 资助金额:
$ 14.14万 - 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
- 批准号:
10932514 - 财政年份:2023
- 资助金额:
$ 14.14万 - 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
- 批准号:
10704845 - 财政年份:2023
- 资助金额:
$ 14.14万 - 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
- 批准号:
10709085 - 财政年份:2023
- 资助金额:
$ 14.14万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10409385 - 财政年份:2022
- 资助金额:
$ 14.14万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10710595 - 财政年份:2022
- 资助金额:
$ 14.14万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10630975 - 财政年份:2022
- 资助金额:
$ 14.14万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
- 批准号:
10710588 - 财政年份:2022
- 资助金额:
$ 14.14万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10788051 - 财政年份:2022
- 资助金额:
$ 14.14万 - 项目类别: